Related references
Note: Only part of the references are listed.Biology of Melanoma
Stephen M. Ostrowski et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels
Marie-Anne Goyette et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Gas6/Axl signaling pathway promotes proliferation, migration and invasion and inhibits apoptosis in A549 cells
Dong Wang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Binding of alpha-ACTN4 to EGF receptor enables its rapid phosphorylation
Hanshuang Shao et al.
HELIYON (2021)
AXL as a Target in Breast Cancer Therapy
Sierra A. Colavito
JOURNAL OF ONCOLOGY (2020)
Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system
Mio Ikeda et al.
CANCER MEDICINE (2020)
EGFR forms ligand-independent oligomers that are distinct from the active state
Patrick O. Byrne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Gas6/Axl Signaling Pathway in the Tumor Immune Microenvironment
Mai Tanaka et al.
CANCERS (2020)
ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL
Silvia Pietrobono et al.
NATURE COMMUNICATIONS (2020)
Cutaneous Melanoma - A Review of Systemic Therapies
Karla A. Lee et al.
ACTA DERMATO-VENEREOLOGICA (2020)
Cross-Talk between Receptor Tyrosine Kinases AXL and ERBB3 Regulates Invadopodia Formation in Melanoma Cells
Or-Yam Revach et al.
CANCER RESEARCH (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
Chenjing Zhu et al.
MOLECULAR CANCER (2019)
Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation
Masami Nozaki et al.
CANCERS (2019)
Tyro3-mediated phosphorylation of ACTN4 at tyrosines is FAK-dependent and decreases susceptibility to cleavage by m-Calpain
Hanshuang Shao et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway
Yangang Ma et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
AXL/AKT axis mediated-resistance to BRAF inhibitor depends on PTEN status in melanoma
Qiang Zuo et al.
ONCOGENE (2018)
Apoptotic Bodies Elicit Gas6-Mediated Migration of AXL-Expressing Tumor Cells
Annelien J. M. Zweemer et al.
MOLECULAR CANCER RESEARCH (2017)
AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier
Masahiro Seike et al.
ONCOLOGY REPORTS (2017)
Giving AXL the axe: targeting AXL in human malignancy
Carl M. Gay et al.
BRITISH JOURNAL OF CANCER (2017)
Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatin
Roman C. Brands et al.
MOLECULAR MEDICINE REPORTS (2016)
Axl-EGFR receptor tyrosine kinase hetero-interaction provides EGFR with access to pro-invasive signalling in cancer cells
M. Vouri et al.
ONCOGENESIS (2016)
Tenascin-C Signaling in melanoma
Hanshuang Shao et al.
CELL ADHESION & MIGRATION (2015)
Multipoint targeting of the PI3K/mTOR pathway in mesothelioma
S. Zhou et al.
BRITISH JOURNAL OF CANCER (2014)
α-Actinin-4 Is Required for Amoeboid-type Invasiveness of Melanoma Cells
Hanshuang Shao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Mueller et al.
NATURE COMMUNICATIONS (2014)
A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
David J. Konieczkowski et al.
CANCER DISCOVERY (2014)
Gas6/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma. patients
Ju Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Gas6 induces cancer cell migration and epithelial-mesenchymal transition through upregulation of MAPK and Slug
Yunhee Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
Aaron S. Meyer et al.
SCIENCE SIGNALING (2013)
Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib
Jeffrey A. Sosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Human Cutaneous Melanomas Lacking MITF and Melanocyte Differentiation Antigens Express a Functional Axl Receptor Kinase
Marialuisa Sensi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Phosphoproteomic Screen Identifies Potential Therapeutic Targets in Melanoma
Kathryn Tworkoski et al.
MOLECULAR CANCER RESEARCH (2011)
Phosphorylation of α-Actinin 4 upon Epidermal Growth Factor Exposure Regulates Its Interaction with Actin
Hanshuang Shao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1
K-Y Tai et al.
ONCOGENE (2008)
Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival
PR van Ginkel et al.
CANCER RESEARCH (2004)
Share Paper
